Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease.☆Insights from the SYNTAX run-in phase
Author(s) -
A. Pieter Kappetein,
Keith D. Dawkins,
Friedrich W. Mohr,
Marie Claude Morice,
Michael J. Mack,
Mary E. Russell,
José Luís Pomar,
Patrick W. Serruys
Publication year - 2006
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2006.01.047
Subject(s) - medicine , percutaneous coronary intervention , cardiology , conventional pci , coronary artery disease , artery , stent , drug eluting stent , left main coronary artery disease , surgery , myocardial infarction
Percutaneous coronary intervention with drug-eluting stents is challenging coronary artery bypass grafting (CABG) as the gold standard for treatment of three-vessel and left main coronary disease. We evaluated the current practice pattern in hospitals throughout Europe and USA.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom